PRINCETON, N.J., Jan. 7, 2011 /PRNewswire/ — EDDA Technology, a
leading provider of advanced computer assisted radiology and
surgery solutions, announces today the successful commercial
installation of its IQQA®-Liver Enterprise product at Mayo
Clinic, Scottsdale, AZ.
As one of the top performing living donor liver transplantation
programs in the US, Mayo Clinic will use EDDA Technology’s
IQQA®-Liver Enterprise in conjunction with its existing
technologies by a multidisciplinary team of surgeons and
radiologists.
With an innovative toolset for real-time interactive assessment
and volumetric quantification of liver, liver lobes, vessels, and
other intra-hepatic anatomies, IQQA®-Liver helps physicians
enhance efficiency and precision in pre-operative treatment
planning and post-surgical follow-up assessment. EDDA’s proprietary
technology has been used to evaluate more than 1,000 clinical cases
at liver surgery/transplantation centers worldwide since the first
commercial installation in 2009. IQQA®-Liver has clearance by
the FDA and China SFDA, and carries the CE mark.
“To understand each individual’s liver anatomy in a quantitative
way is essential to ensure the most suitable surgical approach,”
said David Mulligan, M.D., Chair of Division of Transplant Surgery
at Mayo Clinic in Arizona. “EDDA’s IQQA®-Liver provides us a
comprehensive, quantitative, real-time tool for better treatment
planning with confidence. The ability to make accurate calculations
and change potential surgical approaches within minutes allows safe
planning at optimal patient convenience.”
“The successful installation of IQQA®-Liver Enterprise at
Mayo Clinic indicates that the value of our technology is once
again recognized in assisting physicians to fully utilize the
benefits of quantitative imaging modalities,” said Dr. Jian-Zhong
Qian, President and CEO of EDDA Technology. “EDDA is fully
committed to providing total solutions
‘/>”/>
